<DOC>
	<DOCNO>NCT01360008</DOCNO>
	<brief_summary>Safety efficacy radiofrequency ( RF ) cryoballoon atrial fibrillation ( AF ) ablation investigate cohort study design experience electrophysiologic ( EP ) center analyze propensity-matched cohort .</brief_summary>
	<brief_title>FREEZE Cohort Study</brief_title>
	<detailed_description>Prior participation cohort-study EP center perform minimum 50 RF 50 cryoballoon approach . To insure consecutiveness recruitment , participate center announce intention ablate patient prior procedure coordinate center Ludwigshafen . After inclusion 500 patient well accept criterion AF ablation undergo cryoballoon pulmonary vein isolation ( PVI ) experience german EP center inclusion patient extend european center . A total 4.000 patient include cohort-study , 2.000 cryoballoon RF arm .</detailed_description>
	<criteria>Documented paroxysmal AF ( 2 episode PAF within last 3 month ) Persistent AF ( last &lt; 1 year ) First ablation AF Age ≥18 year Documented inefficacy least 1 AAD include βblockers Written inform consent Longstanding persistent AF last &gt; 1 year Acute coronary syndrome ( ACS ) Heart failure NYHA IV Thrombocytosis , thrombocytopenia Any condition contraindicate chronic anticoagulation Stroke TIA within 6 month prior ablation Uncontrolled hyperthyroidism Pregnancy Life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Cardiac arrhythmia</keyword>
	<keyword>Catheter ablation</keyword>
	<keyword>Cohort Study</keyword>
	<keyword>cryoballoon</keyword>
	<keyword>radiofrequency</keyword>
</DOC>